SCHEMBL9541390

SCHEMBL9541390

COC(=O)c1ccc(OC)cc1C(=O)Cl

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.58
CYP1A2 P05177 1/20 0.58
CYP2D6 P10635 1/20 0.58
CYP2C9 P11712 1/20 0.58
CYP2C19 P33261 1/20 0.58
NR4A2 P43354 1/20 0.50
NPC1 O15118 2/20 0.49
RAB9A P51151 1/20 0.49
CA1 P00915 3/20 0.48
CA2 P00918 3/20 0.48
ALDH1A1 P00352 1/20 0.47
CYP3A4 P08684 1/20 0.47
HPGD P15428 1/20 0.47
MAPK1 P28482 1/20 0.47
GLA P06280 1/20 0.46
GAA P10253 1/20 0.46
HSD17B10 Q99714 1/20 0.46
MAPT P10636 2/20 0.45
ABL1 P00519 1/20 0.45
HTT P42858 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL382822 0.89 KDM4E (0.66) KDM4ECYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL11197823 0.89 NPC1 (0.55) KDM4ECYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL5736385 0.84 KDM4E (0.60) KDM4ECYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL2305372 0.84 ALDH1A1 (0.62) KDM4ECYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL18374571 0.81 KDM4E (0.57) KDM4ECYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL26982038 0.80 KDM4E (0.53) KDM4ECYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL1956889 0.80 KDM4E (0.60) KDM4ECYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL3045867 0.80 ALDH1A1 (0.62) KDM4ECYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL5129370 0.80 ABL1 (0.64) KDM4ECYP1A2CYP2C19NR4A2NPC1
SCHEMBL1180038 0.80 TYK2 (0.57) KDM4ECYP1A2CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1993014086-A1 SUBSTITUTED 1-ISOQUINOLONE DERIVATIVES AS ANGIOTENSIN II ANTAGONISTS SYNTEX (U.S.A.) INC. (US) 1993-07-22 WO disclosed